Clinical Research Centre, Medical University of Białystok, M. Skłodowskiej-Curie 24A, 15-276 Białystok, Poland.
Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Białystok, M. Skłodowskiej-Curie 24A, 15-276 Białystok, Poland.
Int J Mol Sci. 2020 Feb 20;21(4):1455. doi: 10.3390/ijms21041455.
Multiple mechanisms have been suggested to confer to the pathophysiology of metabolic syndrome (MetS), however despite great interest from the scientific community, the exact contribution of each of MetS risk factors still remains unclear. The present study aimed to investigate molecular signatures in peripheral blood of individuals affected by MetS and different degrees of obesity. Metabolic health of 1204 individuals from 1000PLUS cohort was assessed, and 32 subjects were recruited to four study groups: MetS lean, MetS obese, "healthy obese", and healthy lean. Whole-blood transcriptome next generation sequencing with functional data analysis were carried out. MetS obese and MetS lean study participants showed the upregulation of genes involved in inflammation and coagulation processes: granulocyte adhesion and diapedesis ( < 0.0001, = 0.0063), prothrombin activation pathway ( = 0.0032, = 0.0091), coagulation system ( = 0.0010, = 0.0155). The results for "healthy obese" indicate enrichment in molecules associated with protein synthesis ( < 0.0001), mitochondrial dysfunction ( < 0.0001), and oxidative phosphorylation ( < 0.0001). Our results suggest that MetS is related to the state of inflammation and vascular system changes independent of excess body weight. Furthermore, "healthy obese", despite not fulfilling the criteria for MetS diagnosis, seems to display an intermediate state with a lower degree of metabolic abnormalities, before they proceed to a full blown MetS.
多种机制被认为与代谢综合征(MetS)的病理生理学有关,然而,尽管科学界对此非常感兴趣,但 MetS 风险因素中每一个的确切贡献仍不清楚。本研究旨在研究受 MetS 和不同程度肥胖影响的个体外周血中的分子特征。评估了 1000PLUS 队列中的 1204 个人的代谢健康状况,并招募了 32 名参与者进入四个研究组:MetS 瘦组、MetS 肥胖组、“健康肥胖”组和健康瘦组。进行了全血转录组下一代测序和功能数据分析。MetS 肥胖组和 MetS 瘦组的研究参与者表现出参与炎症和凝血过程的基因上调:粒细胞黏附和渗出(<0.0001,=0.0063)、凝血酶原激活途径(=0.0032,=0.0091)、凝血系统(=0.0010,=0.0155)。“健康肥胖”组的结果表明与蛋白质合成(<0.0001)、线粒体功能障碍(<0.0001)和氧化磷酸化(<0.0001)相关的分子富集。我们的结果表明,MetS 与炎症状态和血管系统变化有关,而与体重过剩无关。此外,“健康肥胖”组尽管不符合 MetS 诊断标准,但似乎在发展为完全 MetS 之前,表现出一种代谢异常程度较低的中间状态。